Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock, par value $0.00001 per share
-
Shares outstanding
-
52,942,731
-
Total 13F shares
-
47,118,669
-
Share change
-
+833,771
-
Total reported value
-
$1,088,471,184
-
Price per share
-
$23.10
-
Number of holders
-
98
-
Value change
-
+$8,193,543
-
Number of buys
-
57
-
Number of sells
-
31
Institutional Holders of PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) as of Q4 2021
As of 31 Dec 2021,
PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,118,669 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, INTERWEST VENTURE MANAGEMENT CO, JPMORGAN CHASE & CO, RTW INVESTMENTS, LP, BOXER CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., Euclidean Capital LLC, VIKING GLOBAL INVESTORS LP, and RA CAPITAL MANAGEMENT, L.P..
This page lists
97
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.